Geode Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
KCM
Geode Capital Management's CRBU Position: Q3 2026 in Review
Geode Capital Management increased its Caribou Biosciences (CRBU) stake by 2.7% in Q3 2026, buying an estimated $100K and bringing the position to 2,438,778 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3052.
Geode Capital Management first reported a position in CRBU in Q3 2021 and has held it in 21 quarters since. The position peaked at $10.4M in Q3 2022. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- Geode Capital Management held 2,438,778 shares of Caribou Biosciences worth $3.1M as of Q3 2026.
- Geode Capital Management bought 63,884 Caribou Biosciences shares in Q3 2026, an estimated $100K.
- Caribou Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3052 holding.
- Geode Capital Management first reported a position in Caribou Biosciences in Q3 2021 and has held it in 21 quarters since.
- Geode Capital Management's Caribou Biosciences position peaked at $10.4M in Q3 2022.
- 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.